Marisa Elliott | Director of Business Development
Oligo Factory, Inc.
Marisa has >10 years of experience in life sciences and therapeutics, specializing in gene therapy, neurotechnology, and business development. She joined Oligo Factory in May 2024 as the Director of Business Development covering the Western US & Asia-Pacific regions where she leads strategic growth initiatives in the nucleic acid therapeutics, life sciences and diagnostics sectors.
Prior to joining Oligo Factory, Marisa was Senior Project Manager at BioSpring (April 2021 – May 2024) where she spearheaded projects in gene therapy and strategic project management. Before joining BioSpring, she worked as a Neuroscience and Engineering Consultant, contributing to cutting-edge research and development in neuroscience diagnostics and therapeutics. She started her career as a research assistant and transitioned into customer-facing roles as a technical applications specialist and project manager.
Marisa holds B.Sc. degrees in Bioengineering: Biosystems & Neuroscience and Physiology from the University of California San Diego. With a strong background in biological sciences, business development, and project management, Marisa is passionate about advancing life sciences and biotechnology solutions through strategic growth and industry collaboration.
Appearances:
Festival of Biologics Day 2 @ 11:20
Advancing Therapeutic Oligonucleotide Manufacturing: Oligo Factory’s GMP Solutions for Clinical Success
The increasing demand for high-quality oligonucleotides in therapeutic applications necessitates scalable, efficient, and compliant manufacturing processes. Oligo Factory is at the forefront of this demand, offering ICH Q7 GMP-compliant oligonucleotide manufacturing with a focus on therapeutic oligonucleotides such as ASOs, siRNA, aptamers, and guide RNAs. This presentation will highlight Oligo Factory’s proprietary synthesis platform, scalable production capabilities, and comprehensive analytical services designed to meet rigorous regulatory standards.
Attendees will gain insights into how our U.S.-based and sourced GMP facility streamlines oligonucleotide manufacturing, ensuring the highest quality, rapid turnaround times, and flexible support from late discovery through clinical phases. In addition, we will explain our key process optimizations that enhance efficiency and consistency, enabling the reliable production of complex oligonucleotides for therapeutic development. Join us to explore how Oligo Factory is advancing the next generation of oligonucleotide-based therapies.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events